تحميل
NYSEHealthcareDrug Manufacturers - Specialty & Generic
أحدث البيانات المتاحة
22.92 US$
+0.38 US$ · +1.69%
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
الإغلاق السابق
22.92 US$
+0.38 US$ · +1.69%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
نطاق اليوم
السعر الحالي 22.92 US$
نطاق 52 أسبوعًا
السعر الحالي 22.92 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
35
مرتفع السعر
المشاعر
57
مختلط
المخاطر
41
مخاطر أعلى من المعتاد
الزخم
52
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
نطاق اليوم
السعر الحالي 22.92 US$
نطاق 52 أسبوعًا
السعر الحالي 22.92 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 4.72 مليار USD | 4.44 مليار USD | 4.42 مليار USD | 4.41 مليار USD | 4.76 مليار USD |
| تكلفة البضاعة المباعة | 2.67 مليار USD | 2.53 مليار USD | 2.48 مليار USD | 2.44 مليار USD | 2.69 مليار USD |
| الربح الإجمالي | 2.05 مليار USD | 1.91 مليار USD | 1.94 مليار USD | 1.97 مليار USD | 2.08 مليار USD |
| البحث والتطوير | 368 مليون USD | 344 مليون USD | 327 مليون USD | 321 مليون USD | 369 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 1.43 مليار USD | 1.31 مليار USD | 1.29 مليار USD | 1.27 مليار USD | 1.4 مليار USD |
| نفقات التشغيل | 1.8 مليار USD | 1.66 مليار USD | 1.61 مليار USD | 1.59 مليار USD | 1.77 مليار USD |
| دخل الفوائد | 45 مليون USD | — | — | — | — |
| مصاريف الفوائد | 220 مليون USD | 339 مليون USD | 277 مليون USD | 256 مليون USD | 264 مليون USD |
| الاستهلاك والإطفاء | 680 مليون USD | 662 مليون USD | 694 مليون USD | 682 مليون USD | 716 مليون USD |
| الدخل التشغيلي | 252 مليون USD | 251 مليون USD | 326 مليون USD | 384 مليون USD | 304 مليون USD |
| صافي الدخل | −232 مليون USD | 338 مليون USD | −1.23 مليار USD | −78 مليون USD | −483 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI380.47 مليون0.02%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Morningstar Small-Cap ETFVB274.87 مليون0.15%185.3 مليار USD0.03%289.48 US$+0.64%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV202 مليون0.75%26.81 مليار USD0.33%37.95 US$-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR174.57 مليون0.25%68.2 مليار USD0.05%234.43 US$+0.22%
Vanguard Extended Market ETFVXF138.82 مليون0.14%95.4 مليار USD0.05%235 US$+0.80%
Dimensional - US Targeted Value ETFDFAT130.27 مليون0.43%30.12 مليار USD0.33%67.27 US$-0.43%
Invesco S&P MidCap Momentum ETFXMMO85.65 مليون1.20%7.14 مليار USD0.34%148.79 US$+0.96%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY84.43 مليون0.33%25.82 مليار USD0.23%669.87 US$+0.54%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATInvesco S&P MidCap Momentum ETFXMMOState Street SPDR S&P MIDCAP 400 ETF TrustMDYالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
